Andrew P. Groves
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma (NCT06896110) | Andrew P. Groves | 2025-06-05 |
Track Andrew P. Groves automatically
Every clearance here is in the API, with alerts when new ones post.